A B S T R A C T The endogenous production of carbon monoxide (Vco) in newborn infants was measured by serial determinations of blood carboxyhemoglobin during rebreathing in a closed system. Mean Vco in nine full-term infants was 13.7 zt3.6 Al CO/kg per hr (SD), and in four erythroblastotic infants Vco ranged from 37 to 154 sl CO/kg per hr preceding exchange transfusion. Mean red cell life-span (MLS) and total bilirubin production were calculated from Yco. MLS in normal newborns was 88 :1:15 days (SD), and bilirubin production was 8.5 =12.3 mg/kg per 24 hr. This is more than twice the amount of bilirubin normally produced in the adult per kilogram of body weight. Normal infants achieved a net excretion of bilirubin of at least 5.6 4-2.3 mg/kg per 24 hr (SD) as calculated from the bilirubin production and the measured rise in serum bilirubin concentration.
INTRODUCTION
The recent studies of Coburn and coworkers (1) (2) (3) have confirmed the original observations by Sjbstrand (4-6) that carbon monoxide (CO) is endogenously produced in normal man, and that approximately 1 mole of CO is produced per mole of heme catabolized (2) .
Interest in neonatal hemoglobin turnover has led previous investigators (7) (8) (9) (10) Received for publication 2 January 1970 and in revised form 22 June 1970.
hemoglobin (COHb)1 levels in normal newborn infants and in those with jaundice of hemolytic and nonhemolytic origin. In hemolytic disease of the newborn they demonstrated an elevated level of COHb which was assumed to be due to an increase in CO production (Vco) resulting from increased hemoglobin destruction. Although a correlation has, indeed, been shown to exist between blood COHb and Vco (11, 12) the relationship is too uncertain to derive an accurate indication of hemoglobin turnover from COHb (11).
Wranne (13) (14) (15) and Fallstrbm (12, 16) have measured the pulmonary excretion of CO in newborn infants. This measurement may not accurately reflect CO production because of the difficulty in achieving a steady state between Vco, the critical measurement, and the rate of CO excretion via the lung (11) .
We have adapted Coburn's rebreathing system for the measurement of Vco (1, 17) to the study of newborn infants. With this technique an alteration in CO production can be measured within minutes after it has occurred (18), and we have been able to calculate hemoglobin catabolism, red blood cell survival, and bilirubin production in the newborn infant.
METHODS

Rebreathing circuit
The closed rebreathing circuit is shown in Fig. 1 . The method of sealing the infant's face into the rebreathing mask is similar to that described by Cross (19) .. The infant's face emerges through a pneumatic cuff2 (a) which seals against the face and the surrounding plastic ring (b) onto which a lid is sealed by spring clips. A stop cock (e) allows gas sampling and CO addition at the end of the procedure (see below this rate of flow through the CO2 absorbent (f) (650 ml of Baralyme),' less than 1% CO2 is detectable in the circuit. Humidified oxygen is added via a 50ml syringe at e in amounts sufficient to maintain a constant circuit volume. A thin walled rubber tube, 36 cm long and 6 cm in diameter, is sealed inside a solid plastic tube (c) as illustrated. Rubber stoppers at either end have an outlet for the circulating gas and an additional inlet at one end for oxygen (e). This device allows the addition of oxygen when required without the use of a rubber bag (1) which could act as "dead space" and prevent complete circulation of CO throughout the sytem. A Krogh spirometer (d) is connected to an outlet from the plastic tube and reflects volume changes occurring in the circuit. The use of the spirometer outside of the circuit allows the volume of the system to be kept as small as possible (about 2 liters).
Conduct of study
The infant was placed in the system, and the oxygen tension was adjusted to approximately 150 mm Hg. Thereafter, as oxygen was consumed by the infant, it was replaced so as to maintain circuit volume constant as measured by the spirometer. Oxygen tension was monitored frequently throughout the study4 and adjusted, if necessary, by the addition of extra oxygen. After rebreathing had continued for at least 15 min (1, 17, 20) the first blood sample was taken. Subsequent samples were taken at 30-min intervals for 1 hr. Blood was taken anaerobically either from an indwelling, size 21, scalp vein needle inserted into an antecubital vein, or from free flowing arterialized heel prick samples, the same method of sampling being used throughout a given study. 1 ml of blood was sufficient for duplicate analyses.
Total time involved in the study including the initial equilibration, determination of the dilution factor (see below), insertion of an indwelling needle, and settling the baby into the system, was usually close to 3 hr, by which time most full-term infants were showing signs of restlessness, crying, and/or hunger. When these occurred, leaks' were apt to develop around the baby's face. At the end of the period of observation of the rate of increase of COHb, 0.92 ml (STPD) of 99.5% CO gas, was added to the system at e (Fig. 1) , and a final blood sample was taken 45 min later. The maximum blood CO level measured after the addition of CO was 0.736 ml/100 ml or 3.48% of hemoglobin saturated with CO(1).
Blood analysis
The blood samples were analyzed for CO by liberating bound CO with acidified potassium ferricyanide and a hemolyzing agent (Triton X-100; Rohm and Haas Co., Philadelphia, Pa.). The liberated blood gases were then extracted under vacuum using the modified microgasometer described by Natelson and Stellate (21) followed by injection into a gas chromatograph (Perkin-Elmer 154L). The method of gas injection was modified from Farhi, Edwards, and Homma (22) where the connecting tube leading from the upper two-way stopcock of the microgasometer is connected to two limbs of a four-arm, four-way stopcock. Blood samples of 0.24 ml were drawn up followed by reagents in the following order: 0.025 ml of 1 N lactic acid, 0.024 ml of 10% potassium ferricyanide, 0.1 ml of a solution containing two parts 30% Triton X-100 in saline and one part caprylic alcohol. After the sample and reagents were brought down into the lower reaction chamber under vacuum, the mixtures were agitated for 4 min using the automatic shaker. The extracted gas was then transferred into the carrier stream of helium by the method described by Farhi et al. (22) . Helium at a flow of 50 ml/min carried the gas through the water7 and C028 absorbers into the gas chromatograph. Oxygen, nitrogen, and CO were separated on a i inch X 6 ft column of 13x molecular sieves. Column (and detector) temperature and pressure were 30'C and 10 PSIG, respectively. Voltage change across the thermistor detector bridge was recorded by a 1 mv potentiometric recorder (E. H. Sargent & Co., Springfield, N. J.; model S-72180-25). The apparatus was calibrated by introducing a 3 ml sample of C09 of known concentration into the microgasometer and thence to the chromatograph. The blood COHb saturation was calculated by dividing CO content in milliliter per 100 ml (STPD) by the CO capacity. The CO capacity was determined by multiplying the hemoglobin concentration in grams per 100 ml by 1.34 (23) . All ACOHb% is the average hourly increase in the per cent saturation of hemoglobin with CO (1).
The term COD/ACOHb%D is the dilution of added CO in the body and is determined by adding 0.92 ml (STPD) of 99.5% CO to the circuit (COD), and therefore to the body stores, and measuring the resultant increase in the blood COHb per cent (ACOHb%D).
Mean red cell life span (MLS). shown to reflect bilirubin production in man (27) . Bilirubin production was therefore calculated directly from the measured Vc0 (jsmoles/hr) and the molecular weight of bilirubin:
Bilirubin production (mg/kg per 24 hr) Vco (jumoles/hr) X 0.585 X 24 (6) body weight (kg) where the factor 0.585 is the mg of bilirubin perumole. 10 The rate of rise of COHb will itself be affected by the true size of the total CO pool. When this pool differs significantly from the CO binding capacity of the total circulating hemoglobin (in circumstances where significant amounts of CO are bound outside the circulation), the calculation of circulating hemoglobin cannot be based on CO dilution.
The "retention" of intravascular bilirubin was calculated from the measured rise in serum bilirubin concentration per 24 hr and the plasma volume.
The total bilirubin space has not been measured in the normal newborn infant, but studies in adults suggest that it is equal to about twice the plasma volume (28) . Total body bilirubin was therefore calculated by multiplying the total intravascular bilirubin by two. Excretion of bilirubin was assumed to equal production minus retention.
Plasma volume was calculated from the red cell volume (RCV) and the whole body hematocrit (0.87 X venous hematocrit) (29) . RCV was determined from CO dilution and the hematocrit (30) . con RCV ml = %-W* X hematocrit. (7) measured increase in CO ml/ml Subjects Nine normal newborn infants of 40-41 wk gestation were studied in the first 3 days of life. Permission for the studies was obtained from their informed mothers. None of the mothers received barbiturates during labor (18) or volatile anesthetics during delivery (9) . Ages at the time of study ranged from 27 to 57 hr, and the maximum bilirubin concentration in any of these infants before their discharge on the 5th day was 8 mg/100 ml. Two of the mothers smoked. Their infants were 40 and 47 hr old, respectively, at the time of study, and their levels of blood COHb were well within the normal range (7) (8) (9) .
Four infants with erythroblastosis were studied immediately before the first exchange transfusion. Three of these infants were delivered vaginally; one was an infant of a diabetic mother who was delivered by elective cesarean section under spinal anesthesia. One mother smoked up to the time of delivery, and the possible effect of this on Vco is discussed below. Rebreathing periods in these infants varied from 30 min to 1 hr.
RESULTS
CO production and mean red cell life span (MLS).
The results of studies of CO production in normal and erythroblastotic infants are shown in Fig. 2 . The individual data are presented in Tables I and II . The mean rate of CO production in the normal infants was 13.7 4:3.6 gl CO/kg per hr (SD). In erythroblastotic infants Vco ranged from 37 to 154,l CO/kg per hr. The MLS of the nine normal infants was 88 4115 days (SD).
Bilirubin metabolism. Fig. 3 shows the results of bilirubin production plotted against bilirubin retention in the normal infants.
Reference to Fig. 3 shows that if none of the infants were capable of excreting bilirubin, production would equal retention and all points would fall on the line of identity. The fact that all points fall below the line implies that all of these infants were capable of excreting some bilirubin. The mean rate of bilirubin production in the normal infants was 8 (26, 33) . The MLS of 88 days corresponds well with nearly all of the published data on MLS in the newborn determined by various methods (33) (34) (35) (36) (31, 37, 38) , but red cell volume remains stable during the first 3 days of life (31) and no real decrease in hemoglobin concentration occurs until some time between the 1st and 3rd wk of life (39) . In view of COHb = per cent saturation of hemoglobin with CO; Vco = CO production. * Calculated from estimated blood volume of 75 ml/kg (31, 32) .
t Mother a smoker.
this and the brief duration of the study, the steady-state assumption is probably valid. The determination of total circulating hemoglobin from CO dilution assumes that CO dilution measures circulating red cell volume. Red cell volumes measured by the CO method are 6-16% higher than that measured by the use of 51Cr (30, 40) . This has been attributed to the binding of some of the administered CO by extravascular substances, chiefly myoglobin. No simultaneous measurements using CO and 51Cr have been performed in newborn infants. The newborn has a relatively small muscle mass and probably less myo- (29) . The turnover of bilirubin has not previously been measured in newborn infants because of the difficulty in achieving steady-state conditions and the undesirability of administering labeled bilirubin to infants. Bilirubin Bilirubin Production mg/kg/24hr FIGURE 3 Bilirubin production plotted against retention in nine normal full-term infants (closed circles). The line drawn is that on which points would fall if production equaled retention (i.e., no excretion of bilirubin occurring).
is mainly produced by catabolism of circulating hemoglobin, but also by heme turnover in several other areas including the bone marrow and any tissue containing molecules with heme as a prosthetic group (41), of which the liver appears to be the most important source (42) (43) (44) . The bilirubin from sources other than circulating hemoglobin is commonly referred to as the "early labeled peak" (44, 45) . Our calculations of bilirubin turnover depend on the assumption that the production of CO and bilirubin are proportional. Engel, Berk, Rodkey, Howe, and Berlin (27) measured Vco and endogenous bilirubin production in normal subjects and patients with hemolytic disease. They found an excellent correlation (r = 0.96) between 0co and bilirubin
production. An early labeled CO peak as well as early labeled stercobilin has been demonstrated in patients with ineffective erythropoiesis (45) . Two studies have been reported concerning the early labeled peak in newborn infants. Vest, Strebel, and Hauenstein (26), using glycine-15N in two full-term infants calculated that at least 21-25% of bile pigment excreted in the feces was not derived from senescent erythrocytes. Vest (33) further reported that in two premature infants this fraction was more than 30%.
Jaundice in the normal newborn infant has been attributed to the inability of the liver to conjugate bilirubin due to decreased activity of the glucuronyltransferase enzyme (46) (47) (48) in the face of a relatively "normal" rate of bilirubin production. However, our results indicate that normal newborns produce bilirubin at more than twice the adult rate (per kilogram per 24 hr). Recent studies have suggested that inability to conjugate bilirubin may not be the most important rate limiting step in the excretion of bilirubin in the newborn (49) (50) (51) . Failure of bilirubin uptake and excretion (51) and increased bilirubin production possibly play important roles in this complex problem. Adults produce about 250 mg of bilirubin per day (52) (3.6 mg/kg per day), and the adult's liver may be capable of excreting 10 times the normal rate of bilirubin (53) . Billing, Cole, and Lathe (54) calculated that small newborn infants have only 1-2% of the normal adult capacity for bilirubin excretion. Pearson (34) has calculated bilirubin production from red cell survival studies in newborns and points out that, based on serum bilirubin values normally found on the 3rd day of life, the liver in the newborn infant must have "considerable ability to conjugate and excrete bilirubin." Our findings support this conclusion and suggest that normal full-term infants have at least 15% of the adult capacity for bilirubin excretion.
We did not calculate bilirubin turnover in the erythroblastotic infants because of rapidly changing bilirubin values and uncertainty regarding albumin binding capacity in these infants. In the normal infants (maximum serum bilirubin, 8 mg/100 ml), the primary binding sites for bilirubin on albumin would not be saturated (55) . Our calculations of bilirubin turnover do not consider the possibility of an enterohepatic circulation of bilirubin in the newborn (56) . If such a circulation contributes significantly to the bilirubin load, the ability of the newborn to excrete bilirubin must be even greater than our calculations imply.
